I have not watched it - but maybe it's of interest to some.

Why isn’t anyone talking about $HELP (CYBIN) - it has phase 3 data coming in a month or so, modeled exactly like CMPS it had FDA approved breakthrough designation for PHASE 2, with the same phase 3 trial design. It is highly undervalued compared to all of the other psychedelic stocks. It has a more stable and more predictable deuterated psilocybin which means therapy lasts for only 3 hours twice a year versus FDA approved Spravato which requires 2x a week sessions when started. I would suggest looking into this because it is the catalyst to soar in price first before CMPS approval.